Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: August 20, 2018

DrugPatentWatch Database Preview

Apothecon Company Profile

« Back to Dashboard

What is the competitive landscape for APOTHECON, and what generic and branded alternatives to APOTHECON drugs are available?

APOTHECON has one hundred and fourteen approved drugs.

There are three tentative approvals on APOTHECON drugs.

Summary for Apothecon

US Patents:	0
Tradenames:	77
Ingredients:	47
NDAs:	114

Drugs and US Patents for Apothecon

+ Get email alerts for changes to this table

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Apothecon	DICLOXACILLIN SODIUM	dicloxacillin sodium	FOR SUSPENSION;ORAL	061455-001	Approved Prior to Jan 1, 1982		DISCN	No	No		➤ Sign Up				➤ Sign Up
Apothecon	AMIKIN	amikacin sulfate	INJECTABLE;INJECTION	050495-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No		➤ Sign Up				➤ Sign Up
Apothecon	PENICILLIN G POTASSIUM	penicillin g potassium	TABLET;ORAL	060392-003	Approved Prior to Jan 1, 1982		DISCN	No	No		➤ Sign Up				➤ Sign Up
Apothecon	AMOXICILLIN	amoxicillin	TABLET, CHEWABLE;ORAL	064131-002	May 6, 1996		DISCN	No	No		➤ Sign Up				➤ Sign Up
Apothecon	CEFADYL	cephapirin sodium	INJECTABLE;INJECTION	062724-001	Dec 23, 1986		DISCN	No	No		➤ Sign Up				➤ Sign Up
Apothecon	AMIKIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	amikacin sulfate	INJECTABLE;INJECTION	050618-001	Nov 30, 1987		DISCN	No	No		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Expired US Patents for Apothecon

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Apothecon	CAPOZIDE 50/25	captopril; hydrochlorothiazide	TABLET;ORAL	018709-003	Oct 12, 1984	4,217,347	➤ Sign Up
Apothecon	CAPOZIDE 50/15	captopril; hydrochlorothiazide	TABLET;ORAL	018709-004	Oct 12, 1984	4,105,776	➤ Sign Up
Apothecon	CAPOZIDE 50/15	captopril; hydrochlorothiazide	TABLET;ORAL	018709-004	Oct 12, 1984	4,217,347	➤ Sign Up
Apothecon	STADOL PRESERVATIVE FREE	butorphanol tartrate	INJECTABLE;INJECTION	017857-001	Approved Prior to Jan 1, 1982	3,819,635	➤ Sign Up
Apothecon	CAPOZIDE 50/25	captopril; hydrochlorothiazide	TABLET;ORAL	018709-003	Oct 12, 1984	4,105,776	➤ Sign Up
Apothecon	CAPOZIDE 25/15	captopril; hydrochlorothiazide	TABLET;ORAL	018709-001	Oct 12, 1984	4,217,347	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck

UBS

Julphar

Johnson and Johnson

Moodys

Express Scripts

Medtronic

QuintilesIMS

Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.